Bio-availability of FDCs a major challenge for Indian pharma cos in anti TB
"Drugs stability testing is
proving to be a serious challenge to the pharmaceutical
industry. This is especially critical with reference
to the anti tuberculosis drugs that are showing reduced
bio-availability in composition," stated Dr. Saranjit
Singh representing NIPER, Chandigarh at the 57th IPC.
December 06, 2005